Findings

What do systematic reviews say?

30 questions · 31 findings · 5 reviews

No studies found 10 · 32.3%GRADE not reported 4 · 12.9%Very low 10 · 32.3%Low 6 · 19.4%Moderate 1 · 3.2%High 0 · 0%

Quality of life · women with heavy menstrual bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Days of bleeding · women with heavy menstrual bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Rescue analgesia · analgesia in traumatic corneal abrasions

Topical NSAIDs may leads to lower use of rescue oral analgesia at 24 hours compared with control (low certainty).

2 findings from 1 review

Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions 2017 · Cochrane Headline outcomes only
RR 0.46 [0.34, 0.61]
4 studies · 481 participants
Low
Topical non‐steroidal anti‐inflammatory drugs for analgesia in traumatic corneal abrasions 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Participants with at least 30% or at least 50% reduction in pain · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

PGIC much or very much improved · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Pain no worse than mild at one or two weeks (or equivalent) · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 415 participants
Very low

Serious adverse events · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 949 participants
Very low

Adverse events · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Withdrawals · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Death · people with cancer pain

1 finding from 1 review

Oral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 949 participants
Very low